Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glutathione S-transferase A1 (GSTA1) is a major phase II detoxification enzyme that catalyzes the conjugation of glutathione to a wide variety of electrophilic compounds, including carcinogens, therapeutic drugs, environmental toxins, and products of oxidative stress. It is primarily expressed in the liver and kidney and plays a crucial role in cellular defense and metabolism. GSTA1 also exhibits steroid delta-isomerase and peroxidase activities, further expanding its biological functions.
Catalyzes the conjugation of glutathione to electrophilic compounds, facilitating their detoxification and excretion. Exhibits peroxidase and isomerase activities.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutathione S-transferase A1 (GSTA1).